Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov;11(21):e027733.
doi: 10.1161/JAHA.122.027733. Epub 2022 Oct 31.

Early Changes of Kidney Function Are a Tell for Heart Disease Risk

Sheldon W Tobe  1   2   3
Affiliations
Editorial

Early Changes of Kidney Function Are a Tell for Heart Disease Risk

Sheldon W Tobe. J Am Heart Assoc. 2022 Nov.
No abstract available

Keywords: Editorials; chronic; renal insufficiency.

PubMed Disclaimer

Figures

Figure
Figure. Current chronic kidney disease (CKD) nomenclature used by Kidney Disease: Improving Global Outcomes (KDIGO).
CKD is defined as abnormalities of kidney structure or function, present for >3 months, with implications for health. CKD is classified based on cause, GFR category (G1–G5), and albuminuria category (A1–A3): green indicates low risk (if no other markers of kidney disease, no CKD); yellow, moderately increased risk; orange, high risk; and red, very high risk. GFR indicates glomerular filtration rate. Reproduced from Cheung et al under the terms and conditions of the Creative Commons Attribution (CC‐BY‐NC‐ND) license (https://creativecommons.org/licenses/by‐nc‐nd/4.0/).
See this image and copyright information in PMC

Comment on

References

    1. Murton M, Goff‐Leggett D, Bobrowska A, Garcia Sanchez JJ, James G, Wittbrodt E, Nolan S, Sörstadius E, Pecoits‐Filho R, Tuttle K. Burden of chronic kidney disease by KDIGO categories of glomerular filtration rate and albuminuria: a systematic review. Adv Ther. 2021;38:180–200. doi: 10.1007/s12325-020-01568-8 - DOI - PMC - PubMed
    1. Coresh J. Update on the burden of CKD. J Am Soc Nephrol. 2017;28:1020–1022. doi: 10.1681/ASN.2016121374 - DOI - PMC - PubMed
    1. Kidney Disease: Improving Global Outcomes Blood Pressure Work Group . KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99:S1–S87. doi: 10.1016/j.kint.2020.11.003 - DOI - PubMed
    1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305. doi: 10.1056/NEJMoa041031 - DOI - PubMed
    1. Tobe SW, Clase CM, Gao P, McQueen M, Grosshennig A, Wang X, Teo KK, Yusuf S, Mann JF; Ontarget , et al. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies. Circulation. 2011;123:1098–1107. doi: 10.1161/CIRCULATIONAHA.110.964171 - DOI - PubMed